and technologies

Contract synthesis and purification of highly active pharmacological substances

Along with advancements in medical sciences, the aging of society has created an unprecedented need for improving the health and quality of life.
Even though medications for lifestyle diseases are extensively available, an unfulfilled requirement is treatment for various types of cancers; such anticancer drugs are currently being actively developed. However, from the viewpoint of research and development as well as manufacturing, drugs that are potent in small doses can cause health damage. We began using a containment facility in April 2016 to ensure that such substances are handled in a safe and secure environment.

Based on the combination of our knowledge and years of organic synthesis experience within this facility, we contribute to improving the speed of drug development within this area by providing contract synthesis and purification services for highly active pharmacological substances in a safe and secure manner.

Basic policy for the containment of highly active pharmacological substances

NARD Institute Ltd. contributes to the research, development, and creation of highly potent pharmaceuticals using a newly constructed high-level containment facility as part of its contract synthesis services for chemical compounds.
In addition, we strive to minimize the occupational health and safety issues by actively promoting, establishing, and maintaining a safe and healthy work environment for our employees.

Volume handled Management classification of exposures Containment management
- 100g OEL 0.1 - 1µg/m3 (OEB5) SOP/Exposure sampling

Note: This is not a GMP-compliant facility. β-lactam antibiotics, compounds containing viable bacteria, or hormones containing steroid nucleus cannot be handled.

Facility overview

Figure: Facility for handling highly active pharmacological substances (HEPA filter supply and exhaust system)
Figure: Facility for handling highly active pharmacological substances (HEPA filter supply and exhaust system)
Production room 17m2 (2 hazard rooms) and DG room as well as pass box
Containment facility Hazard room, safety cabinet, draft chamber
Static pressure control -15Pa to -30Pa
Production environment, external environment Class 100K HEPA performance, HEPA exhaust

Inquiries about products and technologies

Please contact us for consultations and inquiries regarding products and technologies.

Contact Us

Recommended contents

Contract synthesis
Highly Active Pharmacological Substances
Contract Manufacturing
Thio-tag Technology
Custom Synthesis of Phos-tag Derivatives
Hydroxy group protecting agent - TriBOT
Organic synthesis support through experimentation and theoretics
NARD Institute, Ltd.